DoW Lupus, Transformative Vision Award
About
Summary: This funding mechanism supports interventional research at the individual and/or health care system level which will result in near-term impact on the health-related quality of life of individuals living with lupus. The emphasis is on near-term impact on quality of life. Research must address at least one of the fiscal year 2026 (FY26) Lupus Research Program (LRP) Transformative Vision Award (TVA) focus areas. This mechanism allows for clinical trials but does not allow animal studies. Distinctive Features: • Applications must include preliminary data. • Applications must include at least one lupus consumer advocate as a member of the research team. • This funding mechanism allows for up to three Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI(s) application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application(s) is rejected or administratively withdrawn. • An individual may be named as PI on only one application per LRP award mechanism (Idea Award, Impact Award, Transformative Vision Development Award, TVA), for a maximum of four applications to the FY26 LRP.
The DoW Lupus Transformative Vision Award funds innovative interventional research designed to create near-term, measurable improvements in the health-related quality of life for individuals living with lupus. This grant supports research at both the individual patient level and within healthcare systems, with a strong emphasis on practical, implementable solutions that deliver real-world health benefits. The program prioritizes clinical research and explicitly welcomes collaborative teams, including up to three Principal Investigators working together on integrated projects. A distinctive requirement is the inclusion of at least one lupus consumer advocate on the research team, ensuring patient perspectives shape the research direction. Unlike many research grants, this mechanism requires applicants to demonstrate preliminary data supporting their proposed work. Researchers should note that clinical trials are permitted under this funding mechanism, though animal studies are not. This award is ideal for research teams committed to bridging the gap between scientific discovery and immediate clinical impact, particularly those addressing the specific FY26 Lupus Research Program focus areas. If you're developing interventional strategies or health system improvements that can demonstrably enhance lupus patients' quality of life in the near term, this grant supports your work with institutional backing and the collaborative structure needed for complex, multi-disciplinary research.
Funding Facts
● Applications openDeadline
August 24, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Amount not specified—contact program for details
Deadline
2026-08-24
Grant Type
federal
Application Cycle
Annual cycle with August 24, 2026 deadline
Best For
Research teams developing interventional strategies and clinical trials to improve lupus patient quality of life, with multi-disciplinary collaboration
Frequently Asked Questions
Who is eligible for DoW Lupus, Transformative Vision Award?
Specific eligibility criteria for this grant program are not provided in the available information. The program does require that research teams include at least one lupus consumer advocate as a research team member. Teams may include up to three Principal Investigators (PIs). An individual may serve as PI on only one application per LRP award mechanism in any given funding cycle, with a maximum of four applications across all FY26 LRP mechanisms. For complete eligibility requirements, institutional affiliations, and other participation criteria, please visit the official Department of War grant program website or contact the Lupus Research Program directly.
How much funding does DoW Lupus, Transformative Vision Award provide?
The specific funding amount or range for this award cycle is not specified in the available program information. Funding amounts may vary by project scope, research focus area, and institutional context. For detailed information about expected funding levels, budget caps, and cost-sharing requirements, consult the official grant announcement or contact the Lupus Research Program.
How do I apply for DoW Lupus, Transformative Vision Award?
The application process involves submitting a pre-application and full application. The initiating PI submits the pre-application, while all partnering PIs must also submit full applications (abbreviated packages specific to their research portion). Applications must include preliminary data supporting the proposed research and demonstrate alignment with FY26 Lupus Research Program Transformative Vision Award focus areas. Note that if either the initiating or partnering application is rejected or administratively withdrawn, all associated applications for that project may be withdrawn. The application deadline is August 24, 2026. For complete submission instructions, required forms, and focus area details, visit the official grant program website.
What can DoW Lupus, Transformative Vision Award funding be used for?
This funding mechanism supports interventional research conducted at the individual patient level or healthcare system level, with a specific focus on creating near-term, measurable improvements in health-related quality of life for people living with lupus. The program funds clinical trials and research addressing designated FY26 Lupus Research Program focus areas. Animal studies are not permitted under this mechanism. Research must include preliminary data and must involve at least one lupus consumer advocate as a team member. The emphasis is on practical, implementable interventions that deliver tangible health benefits in the near term rather than basic science discovery.
Last updated: July 5, 2026